Feb. 7, 2005 -- The European Commission has approved an expanded indication for peginterferon alfa-2a injection, allowing its use in the European Union for the treatment of hepatitis C virus in ...

Co reported on the presentation of results from clinical trials of Velcade based therapies that showed high complete remission / complete response rates in previously treated multiple myeloma patients ...

April 14, 2005 -- The U.S. Food and Drug Administration (FDA) has approved mometasone furoate inhalation powder for the maintenance treatment of asthma as prophylactic therapy in patients aged 12 ...

Boruzu, an injectable presentation of Velcade, has been approved by the FDA for patients who either have multiple myeloma or mantle cell lymphoma. The Food and Drug Administration (FDA) has approved ...

Co reported on the presentation of results from four clinical trials of Velcade based therapies that showed consistently high survival and complete remission / complete response rates in newly ...